Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125240451 | 12524045 | 1 | I | 20160408 | 20160615 | 20160704 | 20160704 | EXP | JP-ROCHE-1779696 | ROCHE | 69.60 | YR | F | Y | 66.00000 | KG | 20160704 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125240451 | 12524045 | 1 | PS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous drip | Y | 103792 | 8 | MG/KG | QD | |||||||
| 125240451 | 12524045 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous drip | Y | 103792 | 6 | MG/KG | Q3W | |||||||
| 125240451 | 12524045 | 3 | SS | ARIMIDEX | ANASTROZOLE | 1 | Oral | 0 | 1 | MG | TABLET | QD | |||||||
| 125240451 | 12524045 | 4 | SS | LOPRESOR SR | METOPROLOL TARTRATE | 1 | Oral | 0 | 60 | MG | TABLET | QD | |||||||
| 125240451 | 12524045 | 5 | SS | AMLODIN | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
| 125240451 | 12524045 | 6 | SS | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | 0 | 8 | MG | TABLET | QD | |||||||
| 125240451 | 12524045 | 7 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 2.5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125240451 | 12524045 | 1 | Breast cancer |
| 125240451 | 12524045 | 3 | Breast cancer |
| 125240451 | 12524045 | 4 | Product used for unknown indication |
| 125240451 | 12524045 | 5 | Product used for unknown indication |
| 125240451 | 12524045 | 6 | Product used for unknown indication |
| 125240451 | 12524045 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125240451 | 12524045 | HO |
| 125240451 | 12524045 | OT |
| 125240451 | 12524045 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125240451 | 12524045 | Cardiac failure | |
| 125240451 | 12524045 | Cardiomegaly | |
| 125240451 | 12524045 | Chordae tendinae rupture | |
| 125240451 | 12524045 | Condition aggravated | |
| 125240451 | 12524045 | Mitral valve incompetence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125240451 | 12524045 | 1 | 20160115 | 0 | ||
| 125240451 | 12524045 | 2 | 20160205 | 20160318 | 0 | |
| 125240451 | 12524045 | 3 | 20151223 | 0 |